China Overturns Pfizer's Viagra Patent

Law360, New York (July 7, 2004, 12:00 AM EDT) -- In a stinging blow to Pfizer, the patent re-examination board of China's State Intellectual Property Office has overturned the company's patent for erectile dysfunction drug Viagra.

In a statement, Pfizer said it was “extremely disheartened by this recent action." The U.S. drug maker said it would appeal, and that its China patent for the anti-impotence drug would remain in effect while it appeals.

SIPO approved Pfizer's patent application for its anti-impotency drug Viagra in late 2001.

But shortly after the patent was approved, twelve of the...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.